Wilson Sonsini Goodrich & Rosati advised InCarda Therapeutics, Inc. on the deal. InCarda Therapeutics, Inc., a privately held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now